5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE

Bibliographic Details
Main Authors:	B. Andemariam, A. Inati, R. Colombatti, C. Minniti, C. Brown, M. Hottmann, S. Gray, C. Hoppe, M. Davis, P. Yue
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000928300.84715.89

Internet